Prosecution Insights
Last updated: October 04, 2026

BIONLIFESCIENCE, INC.

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

BIONLIFESCIENCE, INC. maintains 1 pending office action in the Medical Devices & Mechanical Engineering technology area. This matter is assigned to 1 distinct examiner and is located within 1 distinct art unit. The alignment of these figures suggests that the company's current patent efforts are focused on a specific technical niche within the broader medical device field.

Jeffrey Gerben Hoekstra is identified as the busiest examiner for this portfolio, currently managing 1 pending office action. As the only examiner involved in the company's current pending matters, Hoekstra serves as the primary point of contact for the prosecution of this intellectual property. The busiest examiner pending count of 1 reflects the singular nature of the company's current activity at the USPTO.

With 1 distinct examiner and 1 distinct art unit handling the 1 pending office action, the prosecution profile is highly centralized. This lack of examiner variety may allow for a more predictable interaction, as there are no competing matters or different art unit standards to navigate. Practitioners can focus their strategy entirely on the requirements of the 1 art unit and the specific preferences of Jeffrey Gerben Hoekstra.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§102 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HOEKSTRA, JEFFREY GERBEN 1 56.5% +39.1%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
19333291 SAMPLE COLLECTION STICK HOEKSTRA, JEFFREY GERBEN —

Top Art Units

Art UnitApps
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19333291 SAMPLE COLLECTION STICK HOEKSTRA, JEFFREY GERBEN 3791 §102Other Non-Final OA — Pending Sep 18, 2025

Managing BIONLIFESCIENCE, INC.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month